E Fund Management »

Halozyme Therapeutics shares owned by E Fund Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by E Fund Management from 13F filings

Historical chart of E Fund Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by E Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by E Fund Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $444k 12k 36.96
2023-09-30 $454k 12k 38.23
2023-06-30 $474k 13k 36.04
2023-03-31 $354k 9.3k 38.16
2022-12-31 $423k 7.4k 56.95
2022-09-30 $455k 12k 39.55
2022-06-30 $440k 10k 44.00
2022-03-31 $308k 7.7k 39.87
2021-12-31 $202k 5.0k 40.18
2021-03-31 $130k 3.1k 41.60